Your email has been successfully added to our mailing list.

×
-0.0040287769784173 -0.000143884892086315 -0.00964028776978407 -0.013956834532374 0.00431654676258993 -0.00906474820143881 -0.00676258992805761 0.000143884892086315
Stock impact report

Is It Game Over for Celldex? [The Motley Fool]

Celldex Therapeutics, Inc. (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
Company Research Source: The Motley Fool
Celldex’s lead drug is a flop, but it still has other irons in the fire. Celldex ( NASDAQ:CLDX ) has unveiled thoroughly disappointing results for its lead drug, glembatumumab vedotin (glemba), that casts doubt on its future. Can the company bounce back from this failure? In this clip from The Motley Fool's  Industry Focus: Healthcare , Motley Fool contributor Todd Campbell joins host Kristine Harjes to explain what's next for the company following its decision to halt glemba's development. A full transcript follows the video. This video was recorded on April 18, 2018. Kristine Harjes: Todd, we heard all about Alkermes ' latest news. What else has been going on? Todd Campbell: I think the investors that have followed the Fool for years and years might recognize this second company that I thought we should talk about today, Kristine, and that's Celldex Therapeutics. Harjes: Yeah. Campbell: Do you remember that, Kristine, Celldex? Show less Read more
Impact Snapshot
Event Time:
CLDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLDX alerts
Opt-in for
CLDX alerts

from News Quantified
Opt-in for
CLDX alerts

from News Quantified